SCHEMBL13775003

SCHEMBL13775003

CC1(C)c2ccccc2-c2ccc(N(c3ccc4c(c3)C(C)(C)c3ccccc3-4)c3ccc4c(c3)C3(c5ccccc5-c5ccccc53)c3cc(-n5c6ccccc6c6ccccc65)ccc3-4)cc21

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
PDK2 Q15119 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13774990 0.97 KDM4E (0.33) KDM4EATML3MBTL1PDK2
SCHEMBL15138408 0.95 KDM4E (0.34) KDM4EATML3MBTL1PDK2
SCHEMBL12560147 0.95 KDM4E (0.36) KDM4EATML3MBTL1PDK2
SCHEMBL10029888 0.95 KDM4E (0.36) KDM4EATML3MBTL1PDK2
SCHEMBL18027665 0.94 KDM4E (0.35) KDM4EATML3MBTL1PDK2
SCHEMBL13774996 0.94 KDM4E (0.31) KDM4EATML3MBTL1
SCHEMBL12560084 0.94 KDM4E (0.31) KDM4EATML3MBTL1PDK2
SCHEMBL15138396 0.92 KDM4E (0.32) KDM4EATML3MBTL1PDK2
SCHEMBL14465493 0.92 PDK2 (0.39) KDM4EATML3MBTL1PDK2
SCHEMBL10029885 0.92 KDM4E (0.36) KDM4EATML3MBTL1PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090167161-A1 AROMATIC AMINE DERIVATIVES AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2009-07-02 US disclosed
US-20090167161-A1 AROMATIC AMINE DERIVATIVES AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2009-07-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090167161-A1 AROMATIC AMINE DERIVATIVES AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME TYR, EML4, SLC18A2 KDM4E 619/4885ATM 761/4885L3MBTL1 1053/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.